Two Indian drugmakers seek to end trials of Merck’s antiviral drug for moderate COVID-19 October 8, 2021 Auto Bot News 0 The two Indian drugmakers, Aurobindo Pharma and MSN Laboratories plan to continue late-stage trails of the drug for those with mild COVID-19.
